The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity & Director's Shareholding

9 Mar 2015 16:35

RNS Number : 9497G
Impellam Group plc
09 March 2015
 



 

 

IMPELLAM GROUP PLC

("Impellam", the "Group" or the "Company")

Issue of Equity & Director's Shareholding

 

Further to the acquisition of Lorien Limited ("Lorien") in November 2014, Impellam announces that it has today issued a total of 409,818 ordinary shares of 1p each to the vendors of Lorien at a price of £6.21 per share ("Consideration Shares"). These shares have been issued to part satisfy deferred consideration now payable of £5.09 million, in accordance with the terms of the earn-out. The issue price has been calculated based on the Company's average mid-market closing price over the 20 business day period ended 6 March 2015.The remaining consideration of £2.55 million is to be paid to the vendors in cash by 19 March 2015. As previously announced, a further deferred consideration of up to £13.9 million may be payable in early 2016, subject to earn-out targets being achieved.

 

An application has been made for the Consideration Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur on 13 March 2015. Following Admission, the Company's issued share capital will consist of 49,221,359 ordinary shares.

 

As part of the deferred consideration payment, Derek O'Neill, non-Executive director of Impellam and major shareholder and director of Lorien, and his wife, have been issued 148,968 Consideration Shares and will receive a cash payment of £0.93 million. Following the issue of Consideration Shares, Mr O'Neill's beneficial interest in Impellam, including his wife's interest, is 746,089 ordinary shares representing approximately 1.5 per cent of the Company's enlarged share capital.

 

 

 

Enquiries: For further information please contact the appropriate individual below.

Impellam Group plc

Julia Robertson, Chief Executive

Tel: 01582 692658

Darren Mee, Group Finance Director

Tel: 01582 692658

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

 

Nicholas Wells

Tel: 020 7397 8900

 

 

 

Impellam Group plc, traded on the AIM (Symbol: IPEL) is a leading provider of managed services and specialist staffing expertise and is primarily based in the UK and North America, with smaller operations in Australasia, Ireland and mainland Europe. Impellam Group plc provides fulfilling jobs to doctors, lawyers, accountants, nurses, teachers, scientists, receptionists, drivers, chefs, administrators, engineers, technology specialists, cleaners, security guards, and manufacturing and warehouse operatives through 18 specialist businesses across a broad range of sectors. Impellam Group plc manage them as teams or individually and help clients build better businesses in a changing world. Impellam Group plc is the 2nd largest recruitment business in the UK, 12th worldwide with over 2,500 Impellam people across over 234 locations worldwide.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKDNEDSSEFF
Date   Source Headline
11th May 202310:47 amRNSForm 8.5 (EPT/RI)
11th May 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
10th May 202311:25 amRNSForm 8.3 - Impellam Group PLC
10th May 20239:56 amRNSForm 8.5 (EPT/RI)
10th May 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th May 202311:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th May 202310:54 amRNSForm 8.5 (EPT/RI)
5th May 20231:18 pmRNSForm 8.3 - Impellam Group PLC
5th May 20239:11 amRNSForm 8.5 (EPT/RI)
4th May 20232:30 pmRNSTransaction in Own Shares & Rule 2.9 Announcement
4th May 20238:21 amRNSForm 8.5 (EPT/RI)
3rd May 202311:23 amRNSForm 8.3 - Impellam Group Plc
3rd May 20238:08 amRNSForm 8.5 (EPT/RI)
2nd May 20231:30 pmRNSForm 8.3 - Impellam Group Plc
28th Apr 202312:12 pmRNSForm 8.3 - Impellam Group PLC
28th Apr 202311:05 amRNSForm 8.5 (EPT/RI)
28th Apr 20237:01 amRNSPublication of Annual Report
28th Apr 20237:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 DECEMBER 2022
26th Apr 20231:59 pmRNSForm 8.5 (EPT/RI)
26th Apr 202312:14 pmRNSForm 8.3 - Impellam Group PLC
25th Apr 20237:56 amRNSForm 8.5 (EPT/RI)
21st Apr 202310:29 amRNSForm 8.5 (EPT/RI) - amendment
21st Apr 20239:53 amRNSForm 8.3 - Impellam Group PLC
21st Apr 20237:41 amRNSForm 8.5 (EPT/RI)
21st Apr 20237:00 amRNSRule 2.9 Announcement
21st Apr 20237:00 amRNSTransaction in Own Shares
20th Apr 202311:28 amRNSForm 8.5 (EPT/RI)
20th Apr 20239:00 amRNSRule 2.9 Announcement
20th Apr 20239:00 amRNSTransaction in Own Shares
19th Apr 20239:21 amRNSForm 8.3 - Impellam Group PLC
19th Apr 20237:02 amRNSForm 8.5 (EPT/RI)
17th Apr 20231:44 pmRNSForm 8.3 - Impellam Group Plc
14th Apr 202312:29 pmRNSForm 8.3 - Impellam Group PLC
13th Apr 202312:12 pmRNSForm 8.3 - Impellam Group PLC
11th Apr 202311:45 amRNSForm 8.5 (EPT/RI)
6th Apr 20234:45 pmRNSRule 2.9 Announcement
6th Apr 20234:45 pmRNSTransaction in Own Shares
4th Apr 202311:09 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
4th Apr 20239:00 amRNSRule 2.9 Announcement
4th Apr 20239:00 amRNSTransaction in Own Shares
3rd Apr 202310:59 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
3rd Apr 20239:00 amRNSRule 2.9 Announcement
3rd Apr 20239:00 amRNSTransaction in Own Shares
31st Mar 202311:13 amRNSForm 8.5 (EPT/RI)
31st Mar 20237:00 amRNSRule 2.9 Announcement
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 202310:34 amRNSForm 8.5 (EPT/RI)
30th Mar 20239:30 amRNSRule 2.9 Announcement
30th Mar 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 30 DEC 2022
30th Mar 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.